These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
696 related articles for article (PubMed ID: 21044630)
1. Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Salem R; Lewandowski RJ; Kulik L; Wang E; Riaz A; Ryu RK; Sato KT; Gupta R; Nikolaidis P; Miller FH; Yaghmai V; Ibrahim SM; Senthilnathan S; Baker T; Gates VL; Atassi B; Newman S; Memon K; Chen R; Vogelzang RL; Nemcek AA; Resnick SA; Chrisman HB; Carr J; Omary RA; Abecassis M; Benson AB; Mulcahy MF Gastroenterology; 2011 Feb; 140(2):497-507.e2. PubMed ID: 21044630 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma. Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S; J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371 [TBL] [Abstract][Full Text] [Related]
3. Comparison of yttrium-90 radioembolization and transcatheter arterial chemoembolization for the treatment of unresectable hepatocellular carcinoma. Kooby DA; Egnatashvili V; Srinivasan S; Chamsuddin A; Delman KA; Kauh J; Staley CA; Kim HS J Vasc Interv Radiol; 2010 Feb; 21(2):224-30. PubMed ID: 20022765 [TBL] [Abstract][Full Text] [Related]
4. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial. Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA Trials; 2012 Aug; 13():144. PubMed ID: 22913492 [TBL] [Abstract][Full Text] [Related]
5. 90Y radioembolization versus chemoembolization in the treatment of hepatocellular carcinoma: an analysis of comparative effectiveness. Xing M; Kokabi N; Camacho JC; Kooby DA; El-Rayes BF; Kim HS J Comp Eff Res; 2013 Jul; 2(4):435-44. PubMed ID: 24236684 [TBL] [Abstract][Full Text] [Related]
6. Segmental Yttrium-90 Radioembolization versus Segmental Chemoembolization for Localized Hepatocellular Carcinoma: Results of a Single-Center, Retrospective, Propensity Score-Matched Study. Padia SA; Johnson GE; Horton KJ; Ingraham CR; Kogut MJ; Kwan S; Vaidya S; Monsky WL; Park JO; Bhattacharya R; Hippe DS; Harris WP J Vasc Interv Radiol; 2017 Jun; 28(6):777-785.e1. PubMed ID: 28365172 [TBL] [Abstract][Full Text] [Related]
7. Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma. Salem R; Gordon AC; Mouli S; Hickey R; Kallini J; Gabr A; Mulcahy MF; Baker T; Abecassis M; Miller FH; Yaghmai V; Sato K; Desai K; Thornburg B; Benson AB; Rademaker A; Ganger D; Kulik L; Lewandowski RJ Gastroenterology; 2016 Dec; 151(6):1155-1163.e2. PubMed ID: 27575820 [TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of the safety and efficacy of transcatheter arterial chemoembolization and yttrium-90 radioembolization in patients with unresectable hepatocellular carcinoma. Lance C; McLennan G; Obuchowski N; Cheah G; Levitin A; Sands M; Spain J; Srinivas S; Shrikanthan S; Aucejo FN; Kim R; Menon KV J Vasc Interv Radiol; 2011 Dec; 22(12):1697-705. PubMed ID: 21983055 [TBL] [Abstract][Full Text] [Related]
9. Cost effectiveness of radioembolization compared with conventional transarterial chemoembolization for treatment of hepatocellular carcinoma. Rostambeigi N; Dekarske AS; Austin EE; Golzarian J; Cressman EN J Vasc Interv Radiol; 2014 Jul; 25(7):1075-84. PubMed ID: 24861664 [TBL] [Abstract][Full Text] [Related]
10. Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus Ludwig JM; Zhang D; Xing M; Kim HS Eur Radiol; 2017 May; 27(5):2031-2041. PubMed ID: 27562480 [TBL] [Abstract][Full Text] [Related]
11. Prospective evaluation of patients with early-/intermediate-stage hepatocellular carcinoma with disease progression following arterial locoregional therapy: candidacy for systemic treatment or clinical trials. Memon K; Kulik L; Lewandowski RJ; Gupta R; Ryu RK; Miller FH; Vouche M; Atassi R; Ganger D; Mulcahy MF; Salem R J Vasc Interv Radiol; 2013 Aug; 24(8):1189-1197.e2. PubMed ID: 23474327 [TBL] [Abstract][Full Text] [Related]
12. Survival benefit of radioembolization for inoperable hepatocellular carcinoma using yttrium-90 microspheres. Kwok PC; Leung KC; Cheung MT; Lam TW; Szeto LT; Chou SQ; Chia NH; Tong CM; Yuen PK; Cheung CH; Law CK J Gastroenterol Hepatol; 2014 Nov; 29(11):1897-904. PubMed ID: 24734957 [TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study. Kwon JH; Kim GM; Han K; Won JY; Kim MD; Lee DY; Lee J; Choi W; Kim YS; Kim DY; Han KH Cardiovasc Intervent Radiol; 2018 Mar; 41(3):459-465. PubMed ID: 29067511 [TBL] [Abstract][Full Text] [Related]
14. Locoregional Therapy of Hepatocellular-Cholangiocarcinoma versus Hepatocellular Carcinoma: A Propensity Score-Matched Study. Huang YH; Park BV; Chen YF; Gaba RC; Guzman G; Lokken RP J Vasc Interv Radiol; 2019 Sep; 30(9):1317-1324. PubMed ID: 31375450 [TBL] [Abstract][Full Text] [Related]
16. In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization? El Fouly A; Ertle J; El Dorry A; Shaker MK; Dechêne A; Abdella H; Mueller S; Barakat E; Lauenstein T; Bockisch A; Gerken G; Schlaak JF Liver Int; 2015 Feb; 35(2):627-35. PubMed ID: 25040497 [TBL] [Abstract][Full Text] [Related]
17. A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization. Lewandowski RJ; Kulik LM; Riaz A; Senthilnathan S; Mulcahy MF; Ryu RK; Ibrahim SM; Sato KT; Baker T; Miller FH; Omary R; Abecassis M; Salem R Am J Transplant; 2009 Aug; 9(8):1920-8. PubMed ID: 19552767 [TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization and radioembolization. Sangro B; Salem R Semin Liver Dis; 2014 Nov; 34(4):435-43. PubMed ID: 25369305 [TBL] [Abstract][Full Text] [Related]
19. Radioembolization With Yttrium-90 Resin Microspheres in Hepatocellular Carcinoma: A Multicenter Prospective Study. Kim DY; Park BJ; Kim YH; Han KH; Cho SB; Cho KR; Uhm SH; Choe JG; Choi JY; Chun HJ; Lee HC; Gwon DI; Lee KH; Yoon JH; Chung JW; Kim CW; Heo J; Kim JK; Joo YE Am J Clin Oncol; 2015 Oct; 38(5):495-501. PubMed ID: 24064753 [TBL] [Abstract][Full Text] [Related]
20. Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis. Ozkan ZG; Poyanli A; Ucar A; Kuyumcu S; Akyuz F; Keskin S; Saglam S; Yilmaz E; Karaca C; Turkmen C Cancer Biother Radiopharm; 2015 Apr; 30(3):132-8. PubMed ID: 25760644 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]